A citation-based method for searching scientific literature

Robin Imperial, Omer M Toor, Arif Hussain, Janakiraman Subramanian, Ashiq Masood. Semin Cancer Biol 2019
Times Cited: 33







List of co-cited articles
204 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Oncogenic Signaling Pathways in The Cancer Genome Atlas.
Francisco Sanchez-Vega, Marco Mina, Joshua Armenia, Walid K Chatila, Augustin Luna, Konnor C La, Sofia Dimitriadoy, David L Liu, Havish S Kantheti, Sadegh Saghafinia,[...]. Cell 2018
18

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
12

The 2007 WHO classification of tumours of the central nervous system.
David N Louis, Hiroko Ohgaki, Otmar D Wiestler, Webster K Cavenee, Peter C Burger, Anne Jouvet, Bernd W Scheithauer, Paul Kleihues. Acta Neuropathol 2007
9

RAS Proteins and Their Regulators in Human Disease.
Dhirendra K Simanshu, Dwight V Nissley, Frank McCormick. Cell 2017
729
9

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.
Ethan Cerami, Jianjiong Gao, Ugur Dogrusoz, Benjamin E Gross, Selcuk Onur Sumer, Bülent Arman Aksoy, Anders Jacobsen, Caitlin J Byrne, Michael L Heuer, Erik Larsson,[...]. Cancer Discov 2012
9

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.
Richard S Finn, John P Crown, Istvan Lang, Katalin Boer, Igor M Bondarenko, Sergey O Kulyk, Johannes Ettl, Ravindranath Patel, Tamas Pinter, Marcus Schmidt,[...]. Lancet Oncol 2015
9

The MAPK pathway across different malignancies: a new perspective.
Mauricio Burotto, Victoria L Chiou, Jung-Min Lee, Elise C Kohn. Cancer 2014
518
9

Mutations of the BRAF gene in human cancer.
Helen Davies, Graham R Bignell, Charles Cox, Philip Stephens, Sarah Edkins, Sheila Clegg, Jon Teague, Hayley Woffendin, Mathew J Garnett, William Bottomley,[...]. Nature 2002
9


Cell signaling by receptor tyrosine kinases.
Mark A Lemmon, Joseph Schlessinger. Cell 2010
9

MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study.
Paolo A Ascierto, Dirk Schadendorf, Carola Berking, Sanjiv S Agarwala, Carla Ml van Herpen, Paola Queirolo, Christian U Blank, Axel Hauschild, J Thaddeus Beck, Annie St-Pierre,[...]. Lancet Oncol 2013
486
9

Nerve growth factor eye drop administration improves visual function in a patient with optic glioma.
Antonio Chiaretti, Benedetto Falsini, Serenella Servidei, Dario Marangoni, Filomena Pierri, Riccardo Riccardi. Neurorehabil Neural Repair 2011
12
16



Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation.
Yuan Zhu, Takayuki Harada, Li Liu, Mark E Lush, Frantz Guignard, Chikako Harada, Dennis K Burns, M Livia Bajenaru, David H Gutmann, Luis F Parada. Development 2005
137
6

Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848.
Magdalena Koczkowska, Yunjia Chen, Tom Callens, Alicia Gomes, Angela Sharp, Sherrell Johnson, Meng-Chang Hsiao, Zhenbin Chen, Meena Balasubramanian, Christopher P Barnett,[...]. Am J Hum Genet 2018
91
6

Reprogramming Müller glia via in vivo cell fusion regenerates murine photoreceptors.
Daniela Sanges, Giacoma Simonte, Umberto Di Vicino, Neus Romo, Isabel Pinilla, Marta Nicolás, Maria Pia Cosma. J Clin Invest 2016
46
6

Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy.
Saba Sharif, Rosalie Ferner, Jillian M Birch, James E Gillespie, H Rao Gattamaneni, Michael E Baser, D Gareth R Evans. J Clin Oncol 2006
195
6

Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients.
M R Wallace, D A Marchuk, L B Andersen, R Letcher, H M Odeh, A M Saulino, J W Fountain, A Brereton, J Nicholson, A L Mitchell. Science 1990
6

Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma.
N Lau, M M Feldkamp, L Roncari, A H Loehr, P Shannon, D H Gutmann, A Guha. J Neuropathol Exp Neurol 2000
112
6


Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas.
Tim Forshew, Ruth G Tatevossian, Andrew R J Lawson, Jing Ma, Geoff Neale, Babatunji W Ogunkolade, Tania A Jones, Johan Aarum, James Dalton, Simon Bailey,[...]. J Pathol 2009
216
6


Epidemiology of neurofibromatosis type 1.
J M Friedman. Am J Med Genet 1999
341
6

Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1.
Nicole M Warrington, B Mark Woerner, Girish C Daginakatte, Biplab Dasgupta, Arie Perry, David H Gutmann, Joshua B Rubin. Cancer Res 2007
84
6

Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management.
Carla C P Verstappen, Jan J Heimans, Klaas Hoekman, Tjeerd J Postma. Drugs 2003
270
6

Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.
Robert Listernick, Rosalie E Ferner, Grant T Liu, David H Gutmann. Ann Neurol 2007
344
6

Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients.
T N Basu, D H Gutmann, J A Fletcher, T W Glover, F S Collins, J Downward. Nature 1992
566
6

Ras history: The saga continues.
Adrienne D Cox, Channing J Der. Small GTPases 2010
423
6


Immunohistochemical Markers for Prospective Studies in Neurofibromatosis-1 Porcine Models.
David K Meyerholz, Georgina K Ofori-Amanfo, Mariah R Leidinger, J Adam Goeken, Rajesh Khanna, Jessica C Sieren, Benjamin W Darbro, Dawn E Quelle, Jill M Weimer. J Histochem Cytochem 2017
14
14

Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service.
D G Evans, E Howard, C Giblin, T Clancy, H Spencer, S M Huson, F Lalloo. Am J Med Genet A 2010
479
6

Local delivery of minocycline and systemic BCNU have synergistic activity in the treatment of intracranial glioma.
James L Frazier, Paul P Wang, Daniel Case, Betty M Tyler, Gustavo Pradilla, Jon D Weingart, Henry Brem. J Neurooncol 2003
32
6

Reduced microglial CX3CR1 expression delays neurofibromatosis-1 glioma formation.
Winnie W Pong, Samantha B Higer, Scott M Gianino, Ryan J Emnett, David H Gutmann. Ann Neurol 2013
78
6

Regulatory proteins of R-Ras, TC21/R-Ras2, and M-Ras/R-Ras3.
Y Ohba, N Mochizuki, S Yamashita, A M Chan, J W Schrader, S Hattori, K Nagashima, M Matsuda. J Biol Chem 2000
126
6

mTOR signaling in growth control and disease.
Mathieu Laplante, David M Sabatini. Cell 2012
6

Longitudinal Change of Circumpapillary Retinal Nerve Fiber Layer Thickness in Children With Optic Pathway Gliomas.
Robert A Avery, Avital Cnaan, Joel S Schuman, Carmelina Trimboli-Heidler, Chieh-Li Chen, Roger J Packer, Hiroshi Ishikawa. Am J Ophthalmol 2015
41
6

Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth.
Grant W Simmons, Winnie W Pong, Ryan J Emnett, Crystal R White, Scott M Gianino, Fausto J Rodriguez, David H Gutmann. J Neuropathol Exp Neurol 2011
90
6

Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth.
Aparna Kaul, Joseph A Toonen, Patrick J Cimino, Scott M Gianino, David H Gutmann. Neuro Oncol 2015
59
6


GEFs and GAPs: critical elements in the control of small G proteins.
Johannes L Bos, Holger Rehmann, Alfred Wittinghofer. Cell 2007
6

Comparative characterization of the human and mouse third ventricle germinal zones.
Sonika Dahiya, Da Yong Lee, David H Gutmann. J Neuropathol Exp Neurol 2011
25
8

A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations.
R M Cawthon, R Weiss, G F Xu, D Viskochil, M Culver, J Stevens, M Robertson, D Dunn, R Gesteland, P O'Connell. Cell 1990
986
6

BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas.
Stefan Pfister, Wibke G Janzarik, Marc Remke, Aurélie Ernst, Wiebke Werft, Natalia Becker, Grischa Toedt, Andrea Wittmann, Christian Kratz, Heike Olbrich,[...]. J Clin Invest 2008
344
6

Identification and characterization of the neurofibromatosis type 1 protein product.
J E DeClue, B D Cohen, D R Lowy. Proc Natl Acad Sci U S A 1991
173
6

Histopathology of meningiomas and gliomas of the optic nerve.
M D Marquardt, L E Zimmerman. Hum Pathol 1982
25
8

Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.
Dominique B Hoelzinger, Tim Demuth, Michael E Berens. J Natl Cancer Inst 2007
274
6

Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging.
L J Balcer, G T Liu, G Heller, L Bilaniuk, N J Volpe, S L Galetta, P T Molloy, P C Phillips, A J Janss, S Vaughn,[...]. Am J Ophthalmol 2001
119
6

Optic radiation involvement in optic pathway gliomas in neurofibromatosis.
Grant T Liu, Michael C Brodsky, Peter C Phillips, Jean Belasco, Anna Janss, Jeffrey C Golden, Larissa L Bilaniuk, G Timothy Burson, Ann-Christine Duhaime, Leslie N Sutton. Am J Ophthalmol 2004
40
6

Optic nerve dysfunction in a mouse model of neurofibromatosis-1 optic glioma.
Balazs Hegedus, Frank W Hughes, Joel R Garbow, Scott Gianino, Debasish Banerjee, Keunyoung Kim, Mark H Ellisman, Milam A Brantley, David H Gutmann. J Neuropathol Exp Neurol 2009
36
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.